Advertisement
Screener

SCYNEXIS, Inc. (SCYX) Fair Value Adjustment of Warrants

1.5 / 5 stars · 27/92 Roast Me

SCYNEXIS, Inc. Fair Value Adjustment of Warrants

SCYNEXIS, Inc. (SCYX) reported Fair Value Adjustment of Warrants of -$14.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-10

  • SCYNEXIS, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$14.15M.
  • SCYNEXIS, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $5.25M.
  • SCYNEXIS, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$1.32M.
  • SCYNEXIS, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $640.00K.
  • SCYNEXIS, Inc. fair value adjustment of warrants for fiscal 2025 was -$5.77M.
  • SCYNEXIS, Inc. fair value adjustment of warrants for fiscal 2024 was -$13.81M, a 536.26% decline from fiscal 2023.
  • SCYNEXIS, Inc. fair value adjustment of warrants for fiscal 2023 was $3.17M.
  • SCYNEXIS, Inc. fair value adjustment of warrants for fiscal 2022 was -$22.30M.
Period endFair Value Adjustment of Warrants 3 monthFair Value Adjustment of Warrants 3 month as first filedFair Value Adjustment of Warrants 6 monthFair Value Adjustment of Warrants 9 monthFair Value Adjustment of Warrants 12 monthFair Value Adjustment of Warrants 12 month as first filed
2026-06-30-$14.15M
10-Q · filed 2026-08-10
-$8.90M
10-Q · filed 2026-08-10
-$10.22M
derived: sum of 3 quarters · filed 2026-08-10
-$9.58M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$5.25M
10-Q · filed 2026-05-11
$3.93M
derived: sum of 2 quarters · filed 2026-05-11
$4.57M
derived: sum of 3 quarters · filed 2026-05-11
$2.40M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
-$679.00K
derived: sum of 2 quarters · filed 2026-03-04
-$2.85M
derived: sum of 3 quarters · filed 2026-08-10
-$5.77M
10-K · filed 2026-03-04
2025-09-30$640.00K
10-Q · filed 2025-11-05
-$1.53M
derived: sum of 2 quarters · filed 2026-08-10
-$4.45M
10-Q · filed 2025-11-05
-$7.67M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$2.17M
10-Q · filed 2026-08-10
-$5.09M
10-Q · filed 2026-08-10
-$8.31M
derived: sum of 3 quarters · filed 2026-08-10
-$15.06M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$2.93M
10-Q · filed 2026-05-11
-$6.14M
derived: sum of 2 quarters · filed 2026-05-11
-$12.89M
derived: sum of 3 quarters · filed 2026-05-11
-$7.13M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$3.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
-$9.96M
derived: sum of 2 quarters · filed 2026-03-04
-$4.20M
derived: sum of 3 quarters · filed 2026-03-04
-$13.81M
10-K · filed 2026-03-04
2024-09-30-$6.75M
10-Q · filed 2025-11-05
-$990.00K
derived: sum of 2 quarters · filed 2025-11-05
-$10.60M
10-Q · filed 2025-11-05
-$13.42M
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$5.76M
10-Q · filed 2025-08-13
-$3.85M
10-Q · filed 2025-08-13
-$6.67M
derived: sum of 3 quarters · filed 2025-08-13
-$14.14M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$9.61M
10-Q · filed 2025-05-15
-$12.43M
derived: sum of 2 quarters · filed 2025-05-15
-$19.90M
derived: sum of 3 quarters · filed 2025-05-15
-$28.11M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$2.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
-$10.29M
derived: sum of 2 quarters · filed 2025-03-12
-$18.51M
derived: sum of 3 quarters · filed 2025-03-12
$3.17M
10-K · filed 2025-03-12
2023-09-30-$7.47M
10-Q · filed 2024-11-06
-$15.68M
derived: sum of 2 quarters · filed 2024-11-06
$5.99M
10-Q · filed 2024-11-06
-$3.10M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$8.21M
10-Q · filed 2024-08-08
$13.46M
10-Q · filed 2024-08-08
$4.37M
derived: sum of 3 quarters · filed 2024-08-08
$26.07M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$21.67M
10-Q · filed 2024-05-08
$12.59M
derived: sum of 2 quarters · filed 2024-05-08
$34.29M
derived: sum of 3 quarters · filed 2024-05-08
$24.61M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$9.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$12.61M
derived: sum of 2 quarters · filed 2024-05-08
$2.93M
derived: sum of 3 quarters · filed 2024-05-08
-$22.30M
10-K · filed 2024-03-28
2022-09-30$21.70M
10-Q · filed 2024-05-08
$6.50M
10-Q · filed 2022-11-09
$12.02M
derived: sum of 2 quarters · filed 2024-05-08
-$13.21M
10-Q · filed 2023-11-13
$7.00M
derived: sum of 4 quarters · filed 2024-05-08
2022-06-30-$9.68M
10-Q · filed 2023-08-14
-$19.71M
10-Q · filed 2023-08-14
-$14.70M
derived: sum of 3 quarters · filed 2023-08-14
-$33.51M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$10.03M
10-Q · filed 2023-05-10
-$5.02M
derived: sum of 2 quarters · filed 2023-05-10
-$23.83M
derived: sum of 3 quarters · filed 2023-05-10
-$39.10M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$5.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$13.80M
derived: sum of 2 quarters · filed 2023-03-31
-$29.07M
derived: sum of 3 quarters · filed 2023-03-31
-$30.36M
10-K · filed 2023-03-31
2021-09-30-$18.81M
10-Q · filed 2022-11-09
-$34.08M
derived: sum of 2 quarters · filed 2022-11-09
-$35.38M
10-Q · filed 2022-11-09
-$49.66M
derived: sum of 4 quarters · filed 2023-03-31
2021-06-30-$15.27M
10-Q · filed 2022-08-15
-$16.57M
10-Q · filed 2022-08-15
-$30.85M
derived: sum of 3 quarters · filed 2023-03-31
-$38.64M
derived: sum of 4 quarters · filed 2023-03-31
2021-03-31-$1.30M
10-Q · filed 2022-05-12
-$15.58M
derived: sum of 2 quarters · filed 2023-03-31
-$23.37M
derived: sum of 3 quarters · filed 2023-03-31
-$26.93M
derived: sum of 4 quarters · filed 2023-03-31
2020-12-31-$14.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$22.07M
derived: sum of 2 quarters · filed 2023-03-31
-$25.63M
derived: sum of 3 quarters · filed 2023-03-31
-$30.40M
10-K · filed 2023-03-31
$5.21M
10-K · filed 2021-03-29
2020-09-30-$7.79M
10-Q · filed 2021-11-10
-$11.35M
derived: sum of 2 quarters · filed 2021-11-10
-$16.11M
10-Q · filed 2021-11-10
-$14.26M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$3.56M
10-Q · filed 2021-08-16
-$8.33M
10-Q · filed 2021-08-16
-$6.47M
derived: sum of 3 quarters · filed 2021-08-16
-$8.30M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$4.77M
10-Q · filed 2021-05-17
-$2.91M
derived: sum of 2 quarters · filed 2021-05-17
-$4.74M
derived: sum of 3 quarters · filed 2021-05-17
-$6.79M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
$24.00K
derived: sum of 2 quarters · filed 2021-03-29
-$2.02M
derived: sum of 3 quarters · filed 2021-03-29
$4.50M
10-K · filed 2021-03-29
2019-09-30-$1.83M
10-Q · filed 2020-11-06
-$3.88M
derived: sum of 2 quarters · filed 2020-11-06
$2.64M
10-Q · filed 2020-11-06
-$1.61M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$2.05M
10-Q · filed 2020-08-10
$4.47M
10-Q · filed 2020-08-10
$218.00K
derived: sum of 3 quarters · filed 2020-08-10
-$6.71M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$6.52M
10-Q · filed 2020-05-11
$2.27M
derived: sum of 2 quarters · filed 2020-05-11
-$4.66M
derived: sum of 3 quarters · filed 2020-05-11
-$1.79M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$4.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
-$11.19M
derived: sum of 2 quarters · filed 2020-03-11
-$8.31M
derived: sum of 3 quarters · filed 2020-03-11
-$11.87M
10-K · filed 2020-03-11
2018-09-30-$6.93M
10-Q · filed 2019-11-12
-$4.06M
derived: sum of 2 quarters · filed 2019-11-12
-$7.61M
10-Q · filed 2019-11-12
-$7.53M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$2.87M
10-Q · filed 2019-08-07
-$680.00K
10-Q · filed 2019-08-07
-$600.00K
derived: sum of 3 quarters · filed 2019-08-07
$1.04M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$3.55M
10-Q · filed 2019-05-08
-$3.47M
derived: sum of 2 quarters · filed 2019-05-08
-$1.84M
derived: sum of 3 quarters · filed 2019-05-08
-$4.76M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$80.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$1.72M
derived: sum of 2 quarters · filed 2019-03-14
-$1.21M
derived: sum of 3 quarters · filed 2019-03-14
-$2.73M
10-K · filed 2019-03-14
2017-09-30$1.64M
10-Q · filed 2018-11-13
-$1.29M
derived: sum of 2 quarters · filed 2018-11-13
-$2.81M
10-Q · filed 2018-11-13
-$5.37M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$2.92M
10-Q · filed 2018-08-09
-$4.45M
10-Q · filed 2018-08-09
-$7.01M
derived: sum of 3 quarters · filed 2018-08-09
-$2.44M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$1.52M
10-Q · filed 2018-05-08
-$4.09M
derived: sum of 2 quarters · filed 2018-05-08
$484.00K
derived: sum of 3 quarters · filed 2018-05-08
$383.00K
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31-$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$2.01M
derived: sum of 2 quarters · filed 2018-03-13
$1.91M
derived: sum of 3 quarters · filed 2018-03-13
$1.91M
10-K · filed 2018-03-13
2016-09-30$4.57M
10-Q · filed 2017-11-07
$4.47M
derived: sum of 2 quarters · filed 2017-11-07
$4.47M
10-Q · filed 2017-11-07
$4.47M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30-$101.00K
10-Q · filed 2017-08-08
-$101.00K
10-Q · filed 2017-08-08
-$101.00K
derived: sum of 3 quarters · filed 2017-08-08
-$101.00K
derived: sum of 4 quarters · filed 2017-08-08
2016-03-31$0.00
10-Q · filed 2017-05-08
$0.00
derived: sum of 2 quarters · filed 2017-05-08
$0.00
derived: sum of 3 quarters · filed 2017-05-08
$0.00
derived: sum of 4 quarters · filed 2017-05-08
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$0.00
derived: sum of 2 quarters · filed 2017-03-13
$0.00
derived: sum of 3 quarters · filed 2017-03-13
$0.00
10-K · filed 2017-03-13
2015-09-30$0.00
10-Q · filed 2016-11-07
$0.00
derived: sum of 2 quarters · filed 2016-11-07
$0.00
10-Q · filed 2016-11-07
$10.08M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$0.00
10-Q · filed 2016-08-08
$0.00
10-Q · filed 2016-08-08
$10.08M
derived: sum of 3 quarters · filed 2017-03-13
$10.08M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$0.00
8-K · filed 2015-10-30
$10.08M
derived: sum of 2 quarters · filed 2017-03-13
$10.08M
derived: sum of 3 quarters · filed 2017-03-13
$2.78M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$10.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$10.08M
derived: sum of 2 quarters · filed 2017-03-13
$2.78M
derived: sum of 3 quarters · filed 2017-03-13
$0.00
10-K · filed 2017-03-13
-$10.08M
10-K · filed 2015-03-30
2014-09-30$0.00
10-Q · filed 2015-11-13
-$7.30M
derived: sum of 2 quarters · filed 2015-11-13
-$10.08M
10-Q · filed 2015-11-13
-$2.87M
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30-$7.30M
10-Q · filed 2015-08-19
-$10.08M
10-Q · filed 2015-08-19
-$2.87M
derived: sum of 3 quarters · filed 2015-10-30
-$2.19M
derived: sum of 4 quarters · filed 2015-10-30
2014-03-31-$2.78M
8-K · filed 2015-10-30
$4.43M
derived: sum of 2 quarters · filed 2015-10-30
$5.10M
derived: sum of 3 quarters · filed 2015-10-30
$5.10M
derived: sum of 4 quarters · filed 2015-10-30
2013-12-31$7.21M
derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30
$7.89M
derived: sum of 2 quarters · filed 2015-10-30
$7.89M
derived: sum of 3 quarters · filed 2015-10-30
$7.89M
8-K · filed 2015-10-30
2013-09-30$671.00K
10-Q · filed 2014-11-13
$671.00K
derived: sum of 2 quarters · filed 2014-11-13
$671.00K
10-Q · filed 2014-11-13
2013-06-30$0.00
10-Q · filed 2014-08-13
$0.00
10-Q · filed 2014-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98